The Need for New Approaches to Treating Cancer
On December 23, 1971, President Richard Nixon signed the National Cancer Act, officially declaring America’s “war on cancer.” This watershed moment marked an unprecedented national commitment to combat what had become the country’s second leading cause of death. Nixon’s declaration promised to mobilize the nation’s resources against this formidable enemy, much like the Manhattan Project had done during World War II. The Act significantly increased federal funding for cancer research and established what would become a comprehensive national cancer program.
Fast-forward to today, while we have won significant battles—notably against certain blood cancers, early-stage breast cancer, and some pediatric cancers—we certainly have not won the war. Cancer remains one of humanity’s most formidable adversaries, with metastatic disease in particular continuing to claim millions of lives annually. Contemporary cancer drugs, as research published in both 2004 and 2023 demonstrates (click here and click here), often have a limited impact on enhancing the quality of life or prolonging survival in metastatic cases. This persistence of cancer as a leading cause of death suggests that perhaps we need to take the warfare analogy more literally.
Strategic Warfare Against Cancer
Cancer cells are remarkably adaptable. When we attack them in one way, they often find alternate pathways to survive. Our protocol addresses a critical gap in contemporary cancer treatment. That’s why employ a coordinated strategy that targets several cancer vulnerabilities at once. Think of it as surrounding the enemy from all sides rather than attacking from just one direction. Using a science-based combination of diet and lifestyle, targeted supplements, and, if necessary, carefully chosen repurposed/off-label prescription medications, our multi-pronged attack is designed to:
- Cut off cancer’s fuel sources by reducing cancer’s access to glucose, glutamine, and fatty acids—the key nutrients tumors need to grow and spread.
- Reduce cancer-promoting inflammation by targeting multiple inflammatory pathways that fuel tumor growth and spread
- Normalize the cancer microenvironment by correcting the acidic conditions surrounding tumors that make it easier for cancer to grow and spread
- Block survival mechanisms by preventing cancer cells from using autophagy (a “recycling” process) and repairing pathways that help them survive
- Kill cancer cells by subjecting them to overwhelming levels of oxidative stress
- Target cancer stem cells within tumors to prevent new growth or recurrence
- Help your immune system better recognize and fight the cancer cells.
- Make standard therapies like chemotherapy, radiation, and immunotherapy more effective by reducing the likelihood of cancer developing resistance
Treatment Indications
Based on this comprehensive approach, our treatment may be particularly beneficial for:
- Patients seeking to enhance the effectiveness and/or minimize the side effects of conventional cancer treatment
- Patients who have not responded to or can no longer tolerate conventional treatment
- Patients who do not qualify for a drug trial or failed to respond favorably to a trial drug
- Patients wanting to prolong their remission with health-enhancing strategies
- Patients seeking to improve their quality of life
Patient Care and Treatment Cost
Dr. Thomas’s practice is intentionally limited to no more than 50 patients at any given time—far fewer than the typical oncology caseload of 250 patients. This focused approach enables him to provide highly personalized care and conduct ongoing research to optimize patient outcomes.
For cancers that are aggressive and resistant to conventional treatment, or have recurred, repurposed/off-label prescription medications will be recommended. Before starting these medications, patients must have a physical examination in Dr. Thomas’s office. Blood tests (including CBC, kidney, and liver function) will need to be done throughout treatment to ensure safety, with medication dosages adjusted as needed. Tumor markers and imaging (CT, MRI, or PET/CT) are obtained every three months to monitor treatment progress. Patients have monthly follow-up visits—either in person or via telemedicine—and enjoy unrestricted email access to Dr. Thomas for continuous support.
If you require this degree of ongoing care and medical management, there will be a flat monthly fee. Treatment typically lasts 12 to 18 months or until remission or disease stabilization. Except for bloodwork, neither health insurance nor Medicare covers integrative cancer treatment.